G
BCDAW

GenTrust’s BioCardia, Inc. Warrant BCDAW Stock Holding History

GenTrust’s Portfolio BCDAW Stock Details BCDAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-15,293
Closed -$196 – 235
2024
Q2 		$196 Hold
15,293
– – ﹤0.01% 182
2024
Q1 		$232 Hold
15,293
– – ﹤0.01% 139
2023
Q4 		$191 Hold
15,293
– – ﹤0.01% 130
2023
Q3 		$3.82K Hold
15,293
– – ﹤0.01% 134
2023
Q2 		$11.5K Hold
15,293
– – ﹤0.01% 136
2023
Q1 		$12.7K Hold
15,293
– – ﹤0.01% 141
2022
Q4 		$12.6K Hold
15,293
– – ﹤0.01% 126
2022
Q3 		$4K Hold
15,293
– – ﹤0.01% 123
2022
Q2 		$5K Buy
+15,293
New +$5.97K ﹤0.01% 145

GenTrust's BCDAW Position: Q3 2024 in Review

GenTrust sold out of BioCardia, Inc. Warrant (BCDAW) in Q3 2024, closing a stake of 15,293 shares — an estimated $196 sold.

GenTrust first reported a position in BCDAW in Q2 2022 and held it in 9 quarters. The position peaked at $12.7K in Q1 2023. 0 funds tracked by Wall St. Rank hold BCDAW as of Q3 2024.

  • GenTrust reported no remaining BioCardia, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
  • GenTrust sold 15,293 BioCardia, Inc. Warrant shares in Q3 2024, an estimated $196.
  • GenTrust first reported a position in BioCardia, Inc. Warrant in Q2 2022 and held it in 9 quarters.
  • GenTrust's BioCardia, Inc. Warrant position peaked at $12.7K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held BioCardia, Inc. Warrant as of Q3 2024.

Based on GenTrust's 13F filing for Q3 2024, filed 12 Nov 2024.